文献速递临床生化临床免疫

新型同位素稀释-超高效液相色谱-串联质谱法测定血清C肽方法的建立与验证

Development and Validation of a Novel Isotope Dilution-Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Serum C-Peptide.
PubMed 文献 · Ann Lab Med · 2024-08-23

该研究开发并验证了一种新型同位素稀释-超高效液相色谱-串联质谱(ID-UPLC-MS/MS)法测定血清C肽浓度,评估了精密度、正确度、线性、定量下限、携带污染和基质效应,并与电化学发光免疫分析法(ECLIA)在138例临床标本中进行方法比对。结果显示方法性能可接受,与ECLIA相关性好(R=0.995),但ECLIA存在正偏倚(51.8%)。

要点

  • ID-UPLC-MS/MS法测定血清C肽的精密度和正确度均符合要求。
  • 该方法与ECLIA相关性好(R=0.995),但ECLIA结果存在正偏倚。
  • 该方法适用于临床实验室需准确测定血清C肽的场景。

核心结论

  • 所建立的ID-UPLC-MS/MS法测定血清C肽性能可接受,可用于需要准确测量的临床实验室。

研究设计与样本

  • 方法学开发与验证研究,采用固相萃取、离子交换固相萃取和6-氨基喹啉基-N-羟基琥珀酰亚胺基氨基甲酸酯衍生化预处理样本。
  • 使用ExionLC UPLC系统和Sciex Triple Quad 6500+ MS/MS系统,正离子模式电喷雾电离,多电荷态[M+3H]3+和多反应监测。
  • 总运行时间50分钟,流速0.20 mL/min。
  • 评估精密度、正确度、线性、定量下限、携带污染和基质效应,并与ECLIA在138例临床标本中进行方法比对。

主要发现

  • 批内和批间精密度变异系数均<5%,正确度偏倚值均<4%,均可接受。
  • 验证线性区间为0.050-15 ng/mL,定量下限为0.050 ng/mL。
  • 未观察到显著携带污染或基质效应。
  • 与ECLIA相关性良好(R=0.995,斜率=1.564),但ECLIA显示正偏倚(51.8%)。

临床怎么用

  • 在需要准确测定血清C肽的临床情境中,可考虑使用该ID-UPLC-MS/MS方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mass spectrometry (MS) methods exhibit higher accuracy and comparability in measuring serum C-peptide concentrations than immunoassays. We developed and validated a novel isotope dilution-ultraperformance liquid chromatography-tandem MS (ID-UPLC-MS/MS) assay to measure serum C-peptide concentrations. METHODS: Sample pretreatment involved solid-phase extraction, ion-exchange solid-phase extraction, and derivatization with 6-aminoquinolyl-N-hydroxysuccinimidylcarbamate (Cayman Chemical, Ann Arbor, Michigan, USA). We used an ExionLC UPLC system (Sciex, Framingham, MA, USA) and a Sciex Triple Quad 6500+ MS/MS system (Sciex) for electrospray ionization in positive-ion mode with multiple charge states of [M+3H]3+ and multiple reaction monitoring transitions. The total run time was 50 mins, and the flow rate was 0.20 mL/min. We evaluated the precision, trueness, linearity, lower limit of quantitation (LLOQ), carryover, and matrix effects. Method comparison with electrochemiluminescence immunoassay (ECLIA) was performed in 138 clinical specimens. RESULTS: The intra- and inter-run precision coefficients of variation were <5% and the bias values for trueness were <4%, which were all acceptable. The verified linear interval was 0.050-15 ng/mL, and the LLOQ was 0.050 ng/mL. No significant carryover or matrix effects were observed. The correlation between this ID-UPLC-MS/MS method and ECLIA was good (R=0.995, slope=1.564); however, the ECLIA showed a positive bias (51.8%). CONCLUSIONS: The developed ID-UPLC-MS/MS assay shows acceptable performance in measuring serum C-peptide concentrations. This will be useful in situations requiring accurate measurement of serum C-peptide in clinical laboratories.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Cho SE, Han J, You J, et al. Development and Validation of a Novel Isotope Dilution-Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Serum C-Peptide. Ann Lab Med. 2024. PMID: 39175364. doi:10.3343/alm.2024.0072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。